dalfampridine / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dalfampridine / Generic mfg.
RETROFAM, NCT02966808: Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis

Recruiting
N/A
50
Europe
cognitive and behavioural questionnaires, PASAT, SDMT, MSQoL-54, MSFIS, T25WF, MSWS12
Hospital General Universitario Gregorio Marañon
Multiple Sclerosis
12/21
12/21
NCT05730738: Dalfampridine in Egyptian Patients With Multiple Sclerosis

Recruiting
N/A
100
RoW
Dalfampridine ER, 10 Mg Oral Tablet, Extended Release, Placebo
Ain Shams University
Multiple Sclerosis
12/23
12/24
FamC, NCT05274477: Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

Active, not recruiting
N/A
44
Europe
Fampridine SR, Placebo
Prof. Dominique de Quervain, MD, Clinical Trial Unit, University Hospital Basel, Switzerland, University Hospital, Basel, Switzerland
Working Memory, Post-covid-19
06/24
06/24

Download Options